/Last update -- 24 Dec 2019/ A background context -- opportunities and challenges Current widespread interest towards artificial intelligence (AI) and …
New legislation requiring pharmaceutical companies to implement 'serialization' is now coming into force. This means that no counterfeit product should …
The race for adopting new machine learning (ML), deep learning (DL) and related technologies (for simplicity -- “artificial intelligence”/”AI”) keeps …
The newly organized research project “MELLODDY” (Machine Learning Ledger Orchestration for Drug Discovery), involving ten large pharma companies and seven …
In 1970-80s, the idea of virtual screening was regarded as a conceptual way to substitute costly and time-consuming experimental “screen-everything-you-have” …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.